In addition, studies have reported that the expression of ELMO3 in patients with distant metastases was significantly higher than that in patients without distant metastases in NSCLC patients, and therefore ELMO3 may be a direct driver of cancer metastasis (10, 17). This evidence concerns the gene ELMO3 and non-small cell lung carcinoma.